The reported frequency of mIDH in AML varies, ranging from 7–14% for IDH1 and 8–19% for IDH2, and mutations of either isozyme have been reported in up to 33% of collective cases [33,34,35,36]. The gene discussed is IDH2; the disease is acute myeloid leukemia.